Company Filing History:
2 out of 832,891 Years Active: 2001-2002
Title: Paul D Crowe: Innovator in Multiple Sclerosis Treatment
Introduction
Paul D Crowe is a notable inventor based in Encinitas, CA (US). He has made significant contributions to the field of medical science, particularly in the treatment of multiple sclerosis. With a total of 2 patents, his work focuses on innovative methods that could potentially improve the lives of those affected by this condition.
Latest Patents
Crowe's latest patents include groundbreaking methods for the treatment of multiple sclerosis using peptide analogs of human myelin basic protein. The present invention is directed toward peptide analogs that are at least seven amino acids long and derived from residues 83 to 99 of human myelin basic protein. These analogs are altered from the native sequence at least at positions 91, 95, or 97, with additional alterations possible at other positions. Pharmaceutical compositions containing these peptide analogs are provided, which are useful for treating multiple sclerosis.
Career Highlights
Throughout his career, Paul D Crowe has demonstrated a commitment to advancing medical research and innovation. His work has the potential to make a significant impact on the treatment of multiple sclerosis, showcasing his dedication to improving patient outcomes.
Collaborations
Some of his notable coworkers include Amitabh Gaur and Paul J Conlon. Their collaborative efforts contribute to the innovative research and development in the field of medical treatments.
Conclusion
Paul D Crowe stands out as an influential inventor in the realm of medical science, particularly for his advancements in treating multiple sclerosis. His innovative approaches and dedication to research continue to pave the way for future breakthroughs in healthcare.